Montero R, Chan J, Kollner B, Kuchta R, Vyslouzil J, Podhorec P
Biomolecules. 2022; 12(2).
PMID: 35204827
PMC: 8869309.
DOI: 10.3390/biom12020326.
Coffey J, Gaiha G, Traverso G
Annu Rev Pharmacol Toxicol. 2020; 61:517-540.
PMID: 32466690
PMC: 8057107.
DOI: 10.1146/annurev-pharmtox-030320-092348.
Ogunwuyi O, Kumari N, Smith K, Bolshakov O, Adesina S, Gugssa A
Infect Dis (Auckl). 2016; 9:21-32.
PMID: 27013886
PMC: 4803317.
DOI: 10.4137/IDRT.S38108.
Lee T, Kim D, Won J, Lee I, Sung M, Poo H
J Invest Dermatol. 2013; 134(3):704-711.
PMID: 24025551
DOI: 10.1038/jid.2013.389.
Roger E, Kalscheuer S, Kirtane A, Guru B, Grill A, Whittum-Hudson J
Mol Pharm. 2012; 9(7):2103-10.
PMID: 22670575
PMC: 3461242.
DOI: 10.1021/mp2005388.
Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.
Plummer E, Manchester M
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010; 3(2):174-196.
PMID: 20872839
PMC: 7169818.
DOI: 10.1002/wnan.119.
Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes.
Kadiyala I, Loo Y, Roy K, Rice J, Leong K
Eur J Pharm Sci. 2009; 39(1-3):103-9.
PMID: 19913612
PMC: 2818464.
DOI: 10.1016/j.ejps.2009.11.002.
Polymeric particulates to improve oral bioavailability of peptide drugs.
Delie F, Blanco-Prieto M
Molecules. 2007; 10(1):65-80.
PMID: 18007277
PMC: 6147556.
DOI: 10.3390/10010065.
Past, present, and future technologies for oral delivery of therapeutic proteins.
Singh R, Singh S, Lillard Jr J
J Pharm Sci. 2007; 97(7):2497-523.
PMID: 17918721
PMC: 4627499.
DOI: 10.1002/jps.21183.
Intestinal M cells: the fallible sentinels?.
Miller H, Zhang J, KuoLee R, Patel G, Chen W
World J Gastroenterol. 2007; 13(10):1477-86.
PMID: 17461437
PMC: 1876659.
DOI: 10.3748/wjg.v13.i10.1477.
Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles.
Suresh G, Manjunath K, Venkateswarlu V, Satyanarayana V
AAPS PharmSciTech. 2007; 8(1):24.
PMID: 17408223
PMC: 2750435.
DOI: 10.1208/pt0801024.
Vimentin-positive cells in the epithelium of rabbit ileal villi represent cup cells but not M-cells.
Ramirez C, Gebert A
J Histochem Cytochem. 2003; 51(11):1533-44.
PMID: 14566025
PMC: 3957562.
DOI: 10.1177/002215540305101113.
Vimentin, cytokeratin 8 and cytokeratin 18 are not specific markers for M-cells in human palatine tonsils.
Koshi R, Mustafa Y, Perry M
J Anat. 2002; 199(Pt 6):663-74.
PMID: 11787820
PMC: 1468384.
DOI: 10.1046/j.1469-7580.2001.19960663.x.
M cell-targeted DNA vaccination.
Wu Y, Wang X, Csencsits K, Haddad A, Walters N, Pascual D
Proc Natl Acad Sci U S A. 2001; 98(16):9318-23.
PMID: 11459939
PMC: 55418.
DOI: 10.1073/pnas.161204098.
Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
Jung T, KAMM W, Breitenbach A, Hungerer K, Hundt E, Kissel T
Pharm Res. 2001; 18(3):352-60.
PMID: 11442276
DOI: 10.1023/a:1011063232257.
Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles.
Chen S, Jones D, Fynan E, Farrar G, Clegg J, Greenberg H
J Virol. 1998; 72(7):5757-61.
PMID: 9621034
PMC: 110376.
DOI: 10.1128/JVI.72.7.5757-5761.1998.
Effect of solid and liquid diet on uptake of large particulates across intestinal epithelium in rats.
Simon L, Warren I, Dayan A
Dig Dis Sci. 1997; 42(7):1519-23.
PMID: 9246057
DOI: 10.1023/a:1018883230764.
Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat.
Hussain N, Jani P, Florence A
Pharm Res. 1997; 14(5):613-8.
PMID: 9165532
DOI: 10.1023/a:1012153011884.
The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual.
Florence A
Pharm Res. 1997; 14(3):259-66.
PMID: 9098866
DOI: 10.1023/a:1012029517394.
Targeting to intestinal M cells.
Jepson M, Clark M, Foster N, Mason C, Bennett M, Simmons N
J Anat. 1996; 189 ( Pt 3):507-16.
PMID: 8982824
PMC: 1167691.